Civeo CVEO - -28% - Civeo Affirms Q4 Outlook; Will Suspend Qtr. Dividend; Sees Q1 Sales $160.0M-175.0M vs $228.0M Est; Sees FY2015 Sales $540.0M-600.0M; Civeo Expecting Q1'15 EBITDA $45-$55M, FY15 EBITDA $135-$160M.
XenoPort XNPT - +16% - CNBC's Fast Money @CNBCFastMoney Tweet: RBC's Michael Yee says Xenoport is his under the radar play for 2015 $XNPTDetails
Repros RPRX - +7% - Initiates Two Phase 2B Uterine Fibroid Studies. Expecting dossier to be filed by end of Q1, sees EU dossier submitted by Q1'16.
Jinpan Int'l JST - -5% - Reports Termination of Go-Private Deal
Accenture ACN - +1.4% - wins five-year contract for healthcare.gov work.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in